FDA's No. 2 leaving to helm MD health department
Joshua M. Sharfstein, the second-in-command at the Food and Drug Administration, is leaving that post after less than two years to become Maryland's top public health official, Gov. Martin O'Malley said Tuesday. The offer from O'Malley came two weeks ago after John M. Colmers told the governor that he intended to step down after four years as Maryland's secretary of health and mental hygiene. "I was committed to the FDA. But opportunities like this don't come along very often. It's a really great job at a really important moment in time, and with terrific leadership in the state," Sharfstein said. The new job, which Sharfstein will start next week, touches a broad array of public health issues, including infant mortality, HIV/AIDS, substance abuse, mental health and implementation of healthcare reform.
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Few Winners Among MSSP Participants
- Technology Lights Up Health Innovation Forum
- Data Points to Boom in Private HIX
- EHR Systems 'Immature, Costly,' AMA Says
- NCQA Releases Annual Health Plan Rankings
- Interstate Medical Licensure Effort Advances
- How much does that x-ray cost? You can find out in NH
- Malnourishment 'Epidemic' Plagues Hospitals? Really?
- Hospitals and doctors fail patients by passing the buck on insurance rules